This FTO-driven activation of proangiogenic CAFs significantly promotes tumor progression by fueling angiogenesis in conjunctival melanoma, thereby establishing FTO as a therapeutic target with translational potential for antiangiogenic strategies in oncology [241]. Here, FTO is linked to malignant conjunctival melanoma.